Cox Bryan F., Chief of Research at TriSalus Life Sciences, Inc. ($TLSI), made one open market sale of company shares in the last year, totaling $24,677.52. His most recent sale occurred on May 19, 2025. These sales rank 10,929th among 11,678 individual insiders in our database, far below the average of $8.6 million per seller and 6.4 transactions. Cox Bryan F. reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | S | Common Stock | 1467 | $4.09 | 163,994.0000 | 49,964,311 | 0.89% | 0.00% |
| March 11, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | S | Common Stock | 1138 | $4.13 | 165,461.0000 | 49,964,311 | 0.68% | 0.00% |
| March 16, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | S | Common Stock | 579 | $4.12 | 163,415.0000 | 49,964,311 | 0.35% | 0.00% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 261,954.0000 | 49,964,311 | 43.97% | 0.16% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | A | Common Stock | 40000 | $0.00 | 166,599.0000 | 49,964,311 | 31.60% | 0.08% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | A | Common Stock | 15722 | $5.18 | 124,179.0000 | 32,272,462 | 14.50% | 0.05% |
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | Chief of Research | S | Common Stock | 4764 | $5.18 | 119,415.0000 | 32,272,462 | 3.84% | 0.01% |
| Feb. 18, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF OF RESEARCH | A | Common Stock | 11450 | $0.00 | 108,457.0000 | 0 | 11.80% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF OF RESEARCH | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF OF RESEARCH | A | Common Stock | 10625 | $0.00 | 97,007.0000 | 0 | 12.30% | 0.00% |
| Oct. 5, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | S | Common Stock | 314 | $4.44 | 86,382.0000 | 0 | 0.36% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | A | Employee Stock Option (right to buy) | 63750 | $0.00 | 63,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | A | Common Stock | 14752 | $0.00 | 86,696.0000 | 0 | 20.50% | 0.00% |